BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tékus V, Horváth ÁI, Csekő K, Szabadfi K, Kovács-Valasek A, Dányádi B, Deres L, Halmosi R, Sághy É, Varga ZV, Adeghate E, Kőszegi T, Mátyus P, Gábriel R, Ferdinandy P, Pintér E, Helyes Z. Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats. Biomed Pharmacother 2021;134:111105. [PMID: 33338750 DOI: 10.1016/j.biopha.2020.111105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu X, Xu Y, Li Y, Li M, Wang L, Zhang Q, Zhou B, Lin Q, Gong T, Sun X, Zhang Z, Zhang L. Glucose-responsive erythrocyte-bound nanoparticles for continuously modulated insulin release. Nano Res . [DOI: 10.1007/s12274-022-4105-0] [Reference Citation Analysis]
2 Horváth ÁI, Szentes N, Tékus V, Payrits M, Szőke É, Oláh E, Garami A, Fliszár-Nyúl E, Poór M, Sár C, Kálai T, Pál S, Percze K, Scholz ÉN, Mészáros T, Tóth B, Mátyus P, Helyes Z. Proof-of-Concept for the Analgesic Effect and Thermoregulatory Safety of Orally Administered Multi-Target Compound SZV 1287 in Mice: A Novel Drug Candidate for Neuropathic Pain. Biomedicines 2021;9:749. [PMID: 34209525 DOI: 10.3390/biomedicines9070749] [Reference Citation Analysis]
3 Singh AD, Kulkarni YA. Vascular adhesion protein-1 and microvascular diabetic complications. Pharmacol Rep 2022. [PMID: 35001320 DOI: 10.1007/s43440-021-00343-y] [Reference Citation Analysis]
4 Hernandez-Castillo C, Shuck SC. Diet and Obesity-Induced Methylglyoxal Production and Links to Metabolic Disease. Chem Res Toxicol 2021;34:2424-40. [PMID: 34851609 DOI: 10.1021/acs.chemrestox.1c00221] [Reference Citation Analysis]